{"brief_title": "Major Depressive Disorder Study In Adults", "brief_summary": "A study to obtain safety and tolerability data", "condition": "Major Depressive Disorder", "intervention_type": "Drug", "intervention_name": "paroxetine CR", "criteria": "Inclusion Criteria: - Patient must have primary diagnosis of Major Depressive Disorder (MDD). - Discontinued a selective serotonin reuptake inhibitor (SSRI)or serotonin-norepinephrine reuptake inhibitor (SNRI) regimen due to intolerability. - Minimum time frame between last dose of previous antidepressant and initiation of study drug is one week. - Maximum time frame between last dose of prior antidepressant and initiation of study drug is 2 months. Exclusion Criteria: - Patient has previously been treated with the study drug. - Is experiencing an adverse event attributed to previous SSRI/SNRI use that has not been resolved at least one week prior to Baseline Visit. - Has a history of seizure disorder. - Has met criteria for substance abuse or dependence within 6 months prior to Baseline Visit. - Currently using an antidepressant. - Currently pregnant.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00049972.xml"}